I initiate coverage on Haleon with a "hold" rating due to decent results and potential for ongoing growth, despite a slight revenue slip last year. Haleon's dividend grew 10% and is well-covered ...

February 27, 2025 Sensodyne maker Haleon says 2025 revenue growth skewed to second half British consumer healthcare group Haleon on Thursday said 2025 revenue and profit growth would be weighted ...

Haleon generated £1.9bn in free cash flow, up £369m year-on-year. It reduced net debt to £7.9bn. The company’s leverage ratio improved to 2.8 times net debt to adjusted earnings before ...

Shares of Haleon PLC HLN rallied 4.18% to £3.98 Friday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.61% to 8,809.74.

British multinational healthcare firm Haleon plc (NYSE:HLN) rose for a second day on Monday, adding 3.93 percent to close at ...

Shares of Haleon PLC HLN advanced 2.52% to £3.94 Monday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.41% to 8,768.01.

The projected fair value for Haleon is UK£5.19 based on 2 Stage Free Cash Flow to Equity Current share price of UK£3.91 suggests Haleon is potentially 25% undervalued Analyst price target for ...

Berenberg analyst Bethan Davies raised the firm’s price target on Haleon (HLN) to 457 GBp from 456 GBp and keeps a Buy rating on the shares. See what stocks are receiving Strong Buy ratings from ...

In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against other stocks that lead Monday’s charge amid market bloodbath. The stock market kicked off the trading ...

Consumer healthcare giant Haleon has reported a strong financial performance for 2024, with organic revenue growth of five per cent. However, revenue declined by 0.6 per cent on a reported basis ...